Eos Petro, Inc. entered into an agreement and plan of merger to acquire CellTeck Inc. (OTCBB:CLTK) in a reverse merger transaction on July 16, 2012. Pursuant to the terms of transaction, Eos Petro shareholders will receive one share of Series B preferred stock of CellTeck for each issued and outstanding share of Eos Petro common stock. Each share of Series B preferred stock of CellTeck will be convertible into 800 shares of the CellTeck's common stock pursuant to which the current stockholders of Eos Petro will own in excess of 86% of the outstanding shares of the CellTeck's common stock. Post transaction, Cellteck, Inc. will change its name to Eos Petro, Inc.

Following the consummation of the transaction, CellTeck will have a reconstituted Board of Directors. The Board of Directors of both CellTeck and Eos Petro has approved the transaction. The completion of the transaction is subject to the satisfaction or waiver of certain closing conditions, including, without limitation the approval and adoption by Eos' stockholders and the provision by Eos to Cellteck, of certain financial statements of Eos. Baker & Hostetler LLP acted as the legal advisor for Eos Petro.

Eos Petro, Inc. completed the acquisition of CellTeck Inc. (OTCBB:CLTK) in a reverse merger transaction on October 5, 2012.